Export Ready — 

Effects of 17ß-Estradiol and Endocrine Disruptor Methoxychlor in Spermatogonial Stem Cells: a Protective Effect of Regucalcin?

Bibliographic Details
Main Author: Feijó, Mariana Pombal
Publication Date: 2017
Format: Master thesis
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.6/6732
Summary: Endocrine disrupting chemicals (EDCs) are a set of compounds, either natural or produced by man, that interfere with the endocrine function by altering hormone metabolism, synthesis, and mechanism of action. In the last years, estrogens have emerged as important regulators of germ cell fate, although, the beneficial or detrimental effects of these hormones in spermatogenesis remains controversial, which raised the concern about the EDCs with estrogenic behavior. Methoxychlor (MXC) is an insecticide extensively used in the agricultural sector, which displays endocrine disrupting activity by mimicking estrogens actions (xenoestrogenic). Although it has been proved that MXC can affect the male reproductive function, little is known regarding the impact of this EDC in the spermatogonial stem cell (SSCs) population. SSCs are the adult stem cell population in the testis, having self-renewal capability and high differentiation rates, and its biological activity is the foundation of spermatogenesis. Therefore, any threat disturbing SSCs population can have a detrimental impact on the spermatogenic output and male fertility. Regucalcin (RGN) is a calcium (Ca2+)-binding protein that has been associated with the control of cell proliferation, oxidative stress, apoptosis, and metabolism. Furthermore, the protective role of RGN for the germ cell population upon exposure to damaging factors, such as oxidative stress, apoptosis inducers, freezing, and radiation has been suggested. So, it is highly likely to hypothesize that RGN may have a similar behavior against EDCs actions in SSCs. In the present dissertation, the impact of 17?-estradiol (E2) and MXC on SSCs glycolytic metabolism and survival/apoptosis and the influence of RGN in attenuating their effects were evaluated. For this purpose, a rat spermatogonial stem cell line (GC-6spg) transfected to overexpress RGN (GC6-spg/RGN) was cultured. After confirming RGN overexpression by means of Western blot analysis and immunofluorescence, GC6-spg/RGN cells and mock-transfectants (GC-6spg/Mock) were exposed either to 100 nM of E2 or 25 µM of MXC for 48 hours. Glucose consumption and lactate production, as well as, the expression and activity of glycolytic metabolism and apoptosis regulators were evaluated by spectrophotometric assays and Western blot analysis. The results obtained showed an increased glycolytic activity in GC-6spg cells overexpressing RGN (GC-6spg/RGN) compared to the mock-transfectants, regardless of E2 or MXC treatments, as indicated be the augmented glucose consumption and lactate production. E2 treatment did not affect the glycolytic metabolism of GC-6spg cells, though, in the case of MXC exposure, an enhanced glycolytic metabolism was shown. Nevertheless, RGN overexpression diminished the effect of MXC. Concerning apoptosis, it was found that GC-6spg/RGN cells displayed diminished apoptosis compared with mock-transfectants, namely, by the observed diminution of Bax (proapoptotic)/Bcl-2 (antiapoptotic) protein ratio, p53 expression and caspase-3 activity. E2 also seems to decrease the apoptotic rate of GC-6spg cells whereas upon MXC treatment apoptosis was increased. Interestingly, overall, RGN overexpression tended to counteract E2 and MXC effects over apoptosis. The present study is the first evidence that SSCs metabolism and apoptosis can be modulated by hormonal factors, namely E2 and the EDC with xenoestrogenic properties, MXC. Indeed, MXC was shown to greatly change the apoptotic status and metabolism of GC-6spg cells, with E2-treatment displaying mild effects. Furthermore, RGN was identified as a possible protective mechanism against the damaging effects of MXC in GC-6spg cells. Although preliminary, the obtained findings also highlight for the impact that MXC exposure might have disrupting the SSCs population and compromising male fertility.
id RCAP_9c05bcaf939c8e6749f520341d6f04b0
oai_identifier_str oai:ubibliorum.ubi.pt:10400.6/6732
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Effects of 17ß-Estradiol and Endocrine Disruptor Methoxychlor in Spermatogonial Stem Cells: a Protective Effect of Regucalcin?17ß-EstradiolApoptoseEspermatogónias EstaminaisMetabolismoMetoxicloroRegucalcinaEndocrine disrupting chemicals (EDCs) are a set of compounds, either natural or produced by man, that interfere with the endocrine function by altering hormone metabolism, synthesis, and mechanism of action. In the last years, estrogens have emerged as important regulators of germ cell fate, although, the beneficial or detrimental effects of these hormones in spermatogenesis remains controversial, which raised the concern about the EDCs with estrogenic behavior. Methoxychlor (MXC) is an insecticide extensively used in the agricultural sector, which displays endocrine disrupting activity by mimicking estrogens actions (xenoestrogenic). Although it has been proved that MXC can affect the male reproductive function, little is known regarding the impact of this EDC in the spermatogonial stem cell (SSCs) population. SSCs are the adult stem cell population in the testis, having self-renewal capability and high differentiation rates, and its biological activity is the foundation of spermatogenesis. Therefore, any threat disturbing SSCs population can have a detrimental impact on the spermatogenic output and male fertility. Regucalcin (RGN) is a calcium (Ca2+)-binding protein that has been associated with the control of cell proliferation, oxidative stress, apoptosis, and metabolism. Furthermore, the protective role of RGN for the germ cell population upon exposure to damaging factors, such as oxidative stress, apoptosis inducers, freezing, and radiation has been suggested. So, it is highly likely to hypothesize that RGN may have a similar behavior against EDCs actions in SSCs. In the present dissertation, the impact of 17?-estradiol (E2) and MXC on SSCs glycolytic metabolism and survival/apoptosis and the influence of RGN in attenuating their effects were evaluated. For this purpose, a rat spermatogonial stem cell line (GC-6spg) transfected to overexpress RGN (GC6-spg/RGN) was cultured. After confirming RGN overexpression by means of Western blot analysis and immunofluorescence, GC6-spg/RGN cells and mock-transfectants (GC-6spg/Mock) were exposed either to 100 nM of E2 or 25 µM of MXC for 48 hours. Glucose consumption and lactate production, as well as, the expression and activity of glycolytic metabolism and apoptosis regulators were evaluated by spectrophotometric assays and Western blot analysis. The results obtained showed an increased glycolytic activity in GC-6spg cells overexpressing RGN (GC-6spg/RGN) compared to the mock-transfectants, regardless of E2 or MXC treatments, as indicated be the augmented glucose consumption and lactate production. E2 treatment did not affect the glycolytic metabolism of GC-6spg cells, though, in the case of MXC exposure, an enhanced glycolytic metabolism was shown. Nevertheless, RGN overexpression diminished the effect of MXC. Concerning apoptosis, it was found that GC-6spg/RGN cells displayed diminished apoptosis compared with mock-transfectants, namely, by the observed diminution of Bax (proapoptotic)/Bcl-2 (antiapoptotic) protein ratio, p53 expression and caspase-3 activity. E2 also seems to decrease the apoptotic rate of GC-6spg cells whereas upon MXC treatment apoptosis was increased. Interestingly, overall, RGN overexpression tended to counteract E2 and MXC effects over apoptosis. The present study is the first evidence that SSCs metabolism and apoptosis can be modulated by hormonal factors, namely E2 and the EDC with xenoestrogenic properties, MXC. Indeed, MXC was shown to greatly change the apoptotic status and metabolism of GC-6spg cells, with E2-treatment displaying mild effects. Furthermore, RGN was identified as a possible protective mechanism against the damaging effects of MXC in GC-6spg cells. Although preliminary, the obtained findings also highlight for the impact that MXC exposure might have disrupting the SSCs population and compromising male fertility.Os disruptores endócrinos químicos (EDCs) englobam um conjunto de compostos presentes no meio ambiente, de origem natural ou produzidos pelo homem, e que interferem com a função endócrina através da alteração do metabolismo, síntese e/ou mecanismos de ação hormonal. Nos últimos anos, os estrogénios têm-se revelado importantes reguladores do destino das células germinativas, embora, o efeito destas hormonas na espermatogénese continue a ser alvo de controvérsia. Ainda assim, a informação existente suscita a preocupação relativamente aos efeitos dos EDCs com comportamento estrogénico. O metoxicloro (MXC) é um inseticida extremamente utilizado no sector agrícola, tratando-se de um EDC que atua mimetizando as ações dos estrogénios (xenoestrogénio). Apesar da sua capacidade em influenciar o sistema reprodutor masculino já ter sido demonstrada, não se conhece qual o impacto deste EDC na população de espermatogónias estaminais (SSCs). As SSCs constituem a população de células estaminais adultas presentes no testículo, tendo capacidade de auto-renovação e altas taxas de diferenciação, o que faz com que a sua atividade biológica seja o alicerce da espermatogénese. Assim, qualquer distúrbio que possa ter um efeito nefasto na população de SSCs terá um impacto quantitativo e qualitativo na produção de espermatozóides e, consequentemente, na fertilidade masculina. A regucalcina (RGN) é uma proteína de ligação ao cálcio (Ca2+) que tem sido associada com o controlo da proliferação celular, stress oxidativo, apoptose e metabolismo. Além disso, foi sugerido o papel protetor desta proteína sobre as células germinativas expostas a fatores nocivos, como por exemplo indutores de stress oxidativo e apoptose, congelamento e radiação. Deste modo, é presumível que a RGN possa ter um comportamento semelhante contra as ações dos EDCs nas SSCs. Na presente dissertação, foi estudado o impacto do 17ß-estradiol (E2) e do MXC no metabolismo glicolítico e na sobrevivência/apoptose das SSCs, assim como a influência da RGN na possível atenuação destes efeitos. Com este intuito, uma linha celular de espermatogónias estaminais de rato (GC-6spg), transfetada de modo a sobrexpressar RGN (GC-6spg/RGN), foi mantida em cultura. Após confirmação da sobrexpressão da RGN através de Western blot e imunofluorescência, as células GC-6spg/RGN e as células transfetadas somente com o “vetor vazio” (GC-6spg/Mock) foram expostas a 100 nM de E2 ou 25 µM de MXC durante 48 horas. De seguida, avaliou-se o consumo de glicose e a produção lactato, assim como a expressão e atividade de reguladores do metabolismo glicolítico e da apoptose através de ensaios espectrofotométricos e Western blot. Os resultados obtidos mostraram um aumento da atividade glicolítica nas células GC-6spg que sobrexpressavam RGN (GC-6spg/RGN), comparativamente com células com expressão basal (GC-6spg/Mock), inclusivamente na presença de E2 ou MXC, tendo sido observado um aumento no consumo de glicose e produção de lactato. Por sua vez, o tratamento com E2 não afetou o metabolismo glicolítico das células GC-6spg. No entanto, no caso do tratamento com MXC foi constatado um considerável aumento no fluxo glicolítico, efeito que foi atenuado pela sobrexpressão de RGN. No que diz respeito à apoptose, as células GC-6spg/RGN apresentaram uma diminuição na apoptose, comparativamente com as GC-6spg/Mock, nomeadamente pela diminuição do rácio entre as proteínas Bax (proapoptótica)/Bcl-2 (anti-apoptótica), expressão da p53 e atividade da caspase-3. O tratamento com E2 pareceu diminuir a taxa apoptótica das células GC-6spg, ao passo que no tratamento com MXC as taxas de apoptose estavam aumentadas. De um modo geral, a sobrexpressão da RGN contrariou os efeitos do E2 e do MXC na apoptose destas células. O presente estudo é o primeiro a evidenciar a modulação do metabolismo e da apoptose das SSCs por fatores hormonais, nomeadamente o E2 e o EDC com propriedades xenoestrogénicas, MXC. De facto, o MXC alterou consideravelmente o estado apoptótico e o metabolismo das células GC-6spg, ao passo que o tratamento com E2 apresentou efeitos moderados. Além disso, a RGN foi identificada como um possível fator de proteção contra os efeitos nocivos do MXC nas células GC-6spg. Apesar de ainda numa fase inicial, os resultados obtidos enfatizam o possível impacto negativo que a exposição ao MXC pode ter na população celular de SSCs, com eventual comprometimento da fertilidade masculina.Correia, Sara Carina de LimaSocorro, Sílvia Cristina da Cruz MarquesuBibliorumFeijó, Mariana Pombal2019-10-02T00:30:21Z2017-10-22017-11-032017-11-03T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.6/6732urn:tid:202107590enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-11T15:21:17Zoai:ubibliorum.ubi.pt:10400.6/6732Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T01:25:23.413408Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Effects of 17ß-Estradiol and Endocrine Disruptor Methoxychlor in Spermatogonial Stem Cells: a Protective Effect of Regucalcin?
title Effects of 17ß-Estradiol and Endocrine Disruptor Methoxychlor in Spermatogonial Stem Cells: a Protective Effect of Regucalcin?
spellingShingle Effects of 17ß-Estradiol and Endocrine Disruptor Methoxychlor in Spermatogonial Stem Cells: a Protective Effect of Regucalcin?
Feijó, Mariana Pombal
17ß-Estradiol
Apoptose
Espermatogónias Estaminais
Metabolismo
Metoxicloro
Regucalcina
title_short Effects of 17ß-Estradiol and Endocrine Disruptor Methoxychlor in Spermatogonial Stem Cells: a Protective Effect of Regucalcin?
title_full Effects of 17ß-Estradiol and Endocrine Disruptor Methoxychlor in Spermatogonial Stem Cells: a Protective Effect of Regucalcin?
title_fullStr Effects of 17ß-Estradiol and Endocrine Disruptor Methoxychlor in Spermatogonial Stem Cells: a Protective Effect of Regucalcin?
title_full_unstemmed Effects of 17ß-Estradiol and Endocrine Disruptor Methoxychlor in Spermatogonial Stem Cells: a Protective Effect of Regucalcin?
title_sort Effects of 17ß-Estradiol and Endocrine Disruptor Methoxychlor in Spermatogonial Stem Cells: a Protective Effect of Regucalcin?
author Feijó, Mariana Pombal
author_facet Feijó, Mariana Pombal
author_role author
dc.contributor.none.fl_str_mv Correia, Sara Carina de Lima
Socorro, Sílvia Cristina da Cruz Marques
uBibliorum
dc.contributor.author.fl_str_mv Feijó, Mariana Pombal
dc.subject.por.fl_str_mv 17ß-Estradiol
Apoptose
Espermatogónias Estaminais
Metabolismo
Metoxicloro
Regucalcina
topic 17ß-Estradiol
Apoptose
Espermatogónias Estaminais
Metabolismo
Metoxicloro
Regucalcina
description Endocrine disrupting chemicals (EDCs) are a set of compounds, either natural or produced by man, that interfere with the endocrine function by altering hormone metabolism, synthesis, and mechanism of action. In the last years, estrogens have emerged as important regulators of germ cell fate, although, the beneficial or detrimental effects of these hormones in spermatogenesis remains controversial, which raised the concern about the EDCs with estrogenic behavior. Methoxychlor (MXC) is an insecticide extensively used in the agricultural sector, which displays endocrine disrupting activity by mimicking estrogens actions (xenoestrogenic). Although it has been proved that MXC can affect the male reproductive function, little is known regarding the impact of this EDC in the spermatogonial stem cell (SSCs) population. SSCs are the adult stem cell population in the testis, having self-renewal capability and high differentiation rates, and its biological activity is the foundation of spermatogenesis. Therefore, any threat disturbing SSCs population can have a detrimental impact on the spermatogenic output and male fertility. Regucalcin (RGN) is a calcium (Ca2+)-binding protein that has been associated with the control of cell proliferation, oxidative stress, apoptosis, and metabolism. Furthermore, the protective role of RGN for the germ cell population upon exposure to damaging factors, such as oxidative stress, apoptosis inducers, freezing, and radiation has been suggested. So, it is highly likely to hypothesize that RGN may have a similar behavior against EDCs actions in SSCs. In the present dissertation, the impact of 17?-estradiol (E2) and MXC on SSCs glycolytic metabolism and survival/apoptosis and the influence of RGN in attenuating their effects were evaluated. For this purpose, a rat spermatogonial stem cell line (GC-6spg) transfected to overexpress RGN (GC6-spg/RGN) was cultured. After confirming RGN overexpression by means of Western blot analysis and immunofluorescence, GC6-spg/RGN cells and mock-transfectants (GC-6spg/Mock) were exposed either to 100 nM of E2 or 25 µM of MXC for 48 hours. Glucose consumption and lactate production, as well as, the expression and activity of glycolytic metabolism and apoptosis regulators were evaluated by spectrophotometric assays and Western blot analysis. The results obtained showed an increased glycolytic activity in GC-6spg cells overexpressing RGN (GC-6spg/RGN) compared to the mock-transfectants, regardless of E2 or MXC treatments, as indicated be the augmented glucose consumption and lactate production. E2 treatment did not affect the glycolytic metabolism of GC-6spg cells, though, in the case of MXC exposure, an enhanced glycolytic metabolism was shown. Nevertheless, RGN overexpression diminished the effect of MXC. Concerning apoptosis, it was found that GC-6spg/RGN cells displayed diminished apoptosis compared with mock-transfectants, namely, by the observed diminution of Bax (proapoptotic)/Bcl-2 (antiapoptotic) protein ratio, p53 expression and caspase-3 activity. E2 also seems to decrease the apoptotic rate of GC-6spg cells whereas upon MXC treatment apoptosis was increased. Interestingly, overall, RGN overexpression tended to counteract E2 and MXC effects over apoptosis. The present study is the first evidence that SSCs metabolism and apoptosis can be modulated by hormonal factors, namely E2 and the EDC with xenoestrogenic properties, MXC. Indeed, MXC was shown to greatly change the apoptotic status and metabolism of GC-6spg cells, with E2-treatment displaying mild effects. Furthermore, RGN was identified as a possible protective mechanism against the damaging effects of MXC in GC-6spg cells. Although preliminary, the obtained findings also highlight for the impact that MXC exposure might have disrupting the SSCs population and compromising male fertility.
publishDate 2017
dc.date.none.fl_str_mv 2017-10-2
2017-11-03
2017-11-03T00:00:00Z
2019-10-02T00:30:21Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.6/6732
urn:tid:202107590
url http://hdl.handle.net/10400.6/6732
identifier_str_mv urn:tid:202107590
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833600974788231168